LogicBio Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
LogicBio Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2022.
  • LogicBio Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $385K, a 3.22% increase year-over-year.
  • LogicBio Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.52M, a 16.4% increase from 2020.
  • LogicBio Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $1.3M, a 13.9% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $385K +$12K +3.22% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q1 2021 $373K +$52K +16.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $321K +$122K +61.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $199K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.